Institutions Cut Real Estate Allocations for 2025: Hodes Weill and Cornell Study
By Karen Roman Institutional target allocations to real estate are set to decline in 2025...
Agendia Presents Chemo Prediction Benefits at Symposium
By Karen Roman Agendia, Inc. said it will present MammaPrint’s ability to predict chemotherapy benefit...
Candel Therapeutics Prostate Cancer Therapy Shows Promise
By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer...
Lisata Therapeutics Completes Enrollment for Cancer Therapy Trial
By Karen Roman Biopharma company Lisata Therapeutics, Inc. (Nasdaq: LSTA) said it finished patient enrollment...
ReAlta Presenting New Results in aGVHD at American Society of Hematology 2024
By Karen Roman ReAlta Life Sciences said it is presenting new data at the American...
Nanox.ARC Gets FDA Clearance for Expanded Diagnostic Imaging
By Daniella Nanox (Nasdaq: NNOX), received FDA clearance to produce tomographic images for broader diagnostic...
OmniScience and INmune Bio Partner for Alzheimer’s Trial
By Karen Roman OmniScience and INmune Bio, Inc. (Nasdaq: INMB) said they’re using genAI in...
Agendia’s MammaPrint Optimizes Breast Cancer Therapy
By Karen Roman Agendia, Inc. said its gene expression profiling test MammaPrint can predict...
End of Cable: Private Equity in Media and Entertainment at 4th Palm Beach CorpGov Forum
PE Edge and Exec Edge are pleased to provide complete video coverage of the fourth...
Liquidity in Private Equity at 4th Palm Beach CorpGov Forum
PE Edge and Exec Edge are pleased to provide complete video coverage of the fourth...
© Copyright 2025, ExecEdge